What happened
After reporting fourth-quarter earnings that came up short of expectations, shares of Aratana Therapeutics (NASDAQ:PETX), a biotech company focused on pet health, fell by 21% as of 1:40 p.m. Tuesday.
So what?
Here’s a review of the headline numbers from the fourth quarter:
